Search - tctmd.com

Displaying 101 - 120 of 158

Sort: Relevancy | Date

Presentation TCT 2018

Evolution of Caval Valves (CAVI) Last Resort TR Patients Technology and Clinical Updates

Presenter: Alexander Lauten

September 23, 2018

Presentation TCT 2018

Assessing the Severity of TR: Challenges, Inconsistencies, and Grading Schemes

Presenter: Samir R. Kapadia, Ralph Stephan von Bardeleben, João L Cavalcante

September 23, 2018

Presentation TCT 2018

The Rapid Emergence of Trans-Caval TAVR: Techniques and Clinical Outcomes

Presenter: Adam B. Greenbaum

September 22, 2018

Presentation TCT 2018

Point to Consider in the Review of the RDN Related Devices: US Regulatory

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno, Hiren Mistry

September 22, 2018

Presentation TCT 2018

Japanese Perspective and Experience on RDN Studies

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno

September 22, 2018

Presentation TCT 2018

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

Presenter: Kenneth J. Cavanaugh Jr, Takafumi Ueno, Justin E. Davies

September 22, 2018

Presentation TCT 2018

TCT-73: Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a controlled prospective randomized trial

Presenter: Rebecca T. Hahn, Jose Luis Navia, Maurizio Taramasso, Henryk Dreger

September 21, 2018

Presentation TCT 2018

First-In-Man Testing of a Dedicated Closure Device for Trans-Caval Access for Transcatheter Aortic Valve Replacement (Transmural Systems)

Presenter: Toby Rogers

September 21, 2018

Presentation TCT 2018

Occlusion of the Superior Vena Cava to Reduce Cardiac Filling Pressures is Safe and Feasible in Acutely Decompensated Heart Failure: A First-in-Man Proof of Concept Study

Presenter: Ulrich P. Jorde, John M. Lasala, Navin K. Kapur

September 21, 2018

Presentation The Structural Heart Disease Summit 2018

Evolution of Caval Valves (CAVI)Last Resort TR Patients: Technology and Clinical Updates

Presenter: Alexander Lauten

June 21, 2018

Presentation ISET 2018

Unique Bioconvertible Inferior Vena Cava Filter: One-year Results from the SENTRY Study

Presenter: Michael Dake

February 04, 2018

Presentation TCT 2017

Transcatheter TR Solution 2: Caval Valve Implantation

Presenter: Francesco Maisano, Jason H. Rogers, Hans R. Figulla

November 01, 2017

Presentation TCT 2017

Technical Opportunities Part 2: Telehealth, Cloud-Based Systems, and Centers of Excellence

Presenter: G. Burkhard Mackensen, Robert J. Siegel, João L Cavalcante

November 01, 2017

Presentation TCT 2017

A Retrievable Novel Multi-purpose Inferior Vena Cava filter (Bio2 Medical)

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Luis F. Angel

November 01, 2017

Presentation TCT 2017

The Emergence of Trans-caval TAVR as a Meaningful Alternative Access Approach

Presenter: Toby Rogers

October 31, 2017

Presentation TCT 2017

TAVR Patient Journey II: Imaging Assessment

Presenter: Martina Kelly Speight, João L Cavalcante

October 30, 2017

Presentation TVT 2017

Are Cardiac CT and MRI Necessary to Assess TR Structure or Severity?

Presenter: Robert L. Smith, João L Cavalcante

June 16, 2017

Presentation TVT 2017

Tricuspid Technology 7: CAVI

Presenter: Gregg W. Stone, Alexander Lauten

June 15, 2017

Presentation TVT 2017

How to Quantify MR Using Cardiac MRI

Presenter: Paul A. Grayburn, João L Cavalcante

June 15, 2017

Presentation TVT 2017

Transcatheter Aortic Valve Replacement Through Transcaval Aortic Access in a Patient With Inferior Vena Cava Duplication And Poor Iliofemoral Anatomy

Presenter: Ganesh Manoharan, Zaher Fanari, MD

June 15, 2017

Advertisement

Evolution of Caval Valves (CAVI) Last Resort TR Patients Technology and Clinical Updates

Assessing the Severity of TR: Challenges, Inconsistencies, and Grading Schemes

The Rapid Emergence of Trans-Caval TAVR: Techniques and Clinical Outcomes

Point to Consider in the Review of the RDN Related Devices: US Regulatory

Japanese Perspective and Experience on RDN Studies

The Overview of Current Evidence of RDN: The Result of RADIANCE-HTN SOLO Trial and SPYRAL HTN-on MED Trial

TCT-73: Treatment of Severe TRIcuspid Regurgitation in Patients with Advanced Heart Failure with CAval Vein Implantation of the Edwards Sapien XT VALve (TRICAVAL): a controlled prospective randomized trial

First-In-Man Testing of a Dedicated Closure Device for Trans-Caval Access for Transcatheter Aortic Valve Replacement (Transmural Systems)

Occlusion of the Superior Vena Cava to Reduce Cardiac Filling Pressures is Safe and Feasible in Acutely Decompensated Heart Failure: A First-in-Man Proof of Concept Study

Evolution of Caval Valves (CAVI)Last Resort TR Patients: Technology and Clinical Updates

Unique Bioconvertible Inferior Vena Cava Filter: One-year Results from the SENTRY Study

Transcatheter TR Solution 2: Caval Valve Implantation

Technical Opportunities Part 2: Telehealth, Cloud-Based Systems, and Centers of Excellence

A Retrievable Novel Multi-purpose Inferior Vena Cava filter (Bio2 Medical)

The Emergence of Trans-caval TAVR as a Meaningful Alternative Access Approach

TAVR Patient Journey II: Imaging Assessment

Are Cardiac CT and MRI Necessary to Assess TR Structure or Severity?

Tricuspid Technology 7: CAVI

How to Quantify MR Using Cardiac MRI

Transcatheter Aortic Valve Replacement Through Transcaval Aortic Access in a Patient With Inferior Vena Cava Duplication And Poor Iliofemoral Anatomy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content